There is no content at this time. Please check back later.
COVID-19 Response
Read the full articleCOVID-19 Resource Center Our COVID-19 Resource Center has the information you need. Access clinical and practice management information, patient resources,… COVID-19 Resource Center Our COVID-19 Resource Center has the information you need. Access clinical and practice management information, patient resources, telemedicine help, and more. Visit…
The HOD has been busy
Read the full articleNew leadership will guide the College’s House of Delegates (HOD) this year. The Speaker of the House, M. Razi Rafeeq, MD, FACAAI, and Vice Speaker Andrej Petrov, MD, FACAAI, began their new officer positions at the Town Hall meeting that was held during…
Now is the time to step forward and step up for allergy!
Read the full articleBe part of the College’s nation wide allergy network. We’re looking for dynamic spokespersons to represent the specialty at the local and state level. Put your passion to work! Advocate on behalf of your patients and your specialty – Learn more. Applications accepted…
College Advantage: Winter 2022
Read the full articleTaking your practice to new heights. New and updated College resources can help meet current challenges.… Taking your practice to new heights. New and updated College resources can help meet current challenges.…
Feb. 9 Webinar: Moving Toward Equity: Disparities in Food Allergy
Read the full articlePatients and practitioners are challenged by the everyday inequities in finding and providing food allergy care. Join our 45-minute webinar… Patients and practitioners are challenged by the everyday inequities in finding and providing food allergy care. Join our 45-minute webinar Moving Toward Equity: Disparities in…
CPT Codes for testing to local anesthetics
Read the full articleThe Advocacy Council regularly receives queries from members on how to correctly code specific scenarios. Recently we received a request for coding a local anesthetics testing. Q: What code should I use when I do skin testing and intradermal testing for administration of local…
WANTED: Advocates for Allergy
Read the full articleAllergy needs devoted advocates. Allergy needs spokespeople. Allergy needs YOU! If you’re passionate about your specialty and patients, become a state delegate. Learn more. Applications accepted through Feb. 28. …
Practice Parameters Pocket Guides
in Practice Parameter & Yardstick | Resource Type: MiscRead the full articleWe've partnered with Guideline Central to bring you a set of A/I-focused Pocket Guidelines. These guidelines are accessible, quick-reference tools for practice parameters established by the ACAAI/AAAAI Joint Taskforce on Practice Parameters (JTF). College members have two ways to…
Modifier-93 - New for telehealth
Read the full articleModifier 93 is a new audio-only telemedicine code that went into effect on Jan. 1, 2022. Modifier 93 describes services that are provided via telephone or other real-time interactive audio-only telecommunications system. Use of this modifier is appropriate only if the…
Correction: When to count tests for E/M coding based on MDM
Read the full articleThere has been a great deal of confusion regarding how to count tests/procedures for purposes of coding office visits based on medical decision making (MDM), and the College coding experts have examined these areas of confusion in detail. Based on our review, we…
New Website Spotlights Unique Differences of Eczema in People of Color
Read the full articleIn a mutual commitment to address disparities in treating eczema in skin of color, the American College of Allergy, Asthma and Immunology (ACAAI) and the Allergy and Asthma Network have partnered to create EczemaInSkinofColor.org, a campaign to aid physicians and patients in recognizing…
FDA Issues Memorandum of Understanding on compounded drugs
Read the full articleThe Food and Drug Administration (FDA) recently issued a Memorandum of Understanding (MOU) related to the interstate distribution of compounded drugs. If a state Board of Pharmacy or other appropriate state agency decides to enter into this MOU with the FDA, pharmacies and physicians…
Spotlight on the New Allergists Committee
Read the full articleThe College is keenly focused on providing members with timely and relevant resources they can apply in their practices and in treating patients, as well as obtaining CME and other professional development. Younger members (or those new to the specialty) may have different needs…
Grow your leadership skills
Read the full articleOn March 26-27, the College will host its Leadership Summit: Generation Next. The event, which has been held annually since 2018, is specifically designed for young physician members (45 years of age or younger or in first 10 years of practice) who are…
Your leadership's decisions - Winter 2022 Committee Insider
Read the full articleThe following are key actions taken by the ACAAI Board of Regents during its Nov. 4 meeting. Agreed to continue… The following are key actions taken by the ACAAI Board of Regents during its Nov. 4 meeting. Agreed to continue to co-sponsor the 2022 Program…
Your questions answered - Winter 2022
Read the full articleWe asked Michael Blaiss, MD, FACAAI, executive medical director, about the opportunities and challenges for young leaders. An important aspect of the College’s strategic plan, Vision Forward, is to continue to build leadership pathways. How has the College approached finding and mentoring emerging…
Improving Access to Treatment for PIDD in Minority/Underserved Populations
in AllergyTalkRead the full articleThe third episode will outline barriers to immune globulin and transplantation and offer solutions for Primary Immunodeficiency Disorders (PIDD).… This podcast is supported by Pfizer. The third of three podcasts will outline barriers to immune globulin and transplantation and offer solutions for patients with…
Addressing the Barriers to Diagnosis of PIDD in Minority/Underserved Populations
in AllergyTalkRead the full articleThis episode will outline each barrier discussed in podcast #1 and then offer resources and solutions.… This podcast miniseries is supported by Pfizer. In this, the second of three podcasts focusing on patients with Primary Immunodeficiency Disorders (PIDD), each barrier from podcast #1 is…
Underdiagnosis of PIDD in Minority/Underserved Populations
in AllergyTalkRead the full articleThis episode will review the current evidence of underdiagnosis of PIDD in minority/underserved populations.… This podcast is supported by Pfizer. The first episode of the Primary Immunodeficiency Disorders (PIDD) miniseries will review the current evidence of underdiagnosis of PIDD in minority/underserved populations. The miniseries…
There are no posts at this time. Please check back later.